The Perfect Data Myth: What You Really Need to Start Seeing Impact from Omnichannel In this session, we cover: How we should be evaluating the impact of our omnichannel investments, and how we can measure whether or not we’re positively impacting the customer experience What common misconceptions life sciences organizations have about their readiness to […]
Chat: We can be Heroes – Pharma’s Purposeful 2022 Outlook Pharma’s transformation journey is still ongoing, but more than ever, we’re searching to deliver more meaningful, high-value experiences to patients, payers and physicians. From commercial excellence to making patient-centricity a reality, this conversation explores the challenges and opportunities of the upcoming year. In this […]
『アナリティクスの価値を最大限引き出す Aktanaコンサルティングサービス』 2021年9月30日に行われました「Medinew Digital Marketing Day 2021」にて、弊社のアナリティクス・コンサルティング・ディレクターである小林哲郎が『アナリティクスの価値を最大限引き出す Aktanaコンサルティングサービス』と題して講演しました。講演の後半は、ノバルティスファーマ株式会社の山田俊範様にもご登壇いただき、データ分析等に関するトークセッションを行いました。
From Siloed to Synched at Scale: Migrating to a Collaborative, Omnichannel Commercial Model In this session, we cover: How the most successful omnichannel programs bring brand, field, and intelligence together to create seamless customer experiences for HCPs How different organizations are working effectively across teams to coordinate meaningful customer journeys and deliver true omnichannel at […]
“Digital channels haven’t just changed for the pandemic. They’ve changed permanently.” – Greg Carpenter, Sr. Director, US Transformation Lead for Sanofi General Medicines After being thrown into the digital deep end, the life sciences industry has finally evolved to a fully mixed model of engagement. Now, it’s time for pharma to reimagine what a meaningful […]
We were thrilled to watch our VP of Services Effectiveness and Innovation, Bruce Carlson, share the virtual stage with Ferring’s Global Head of Digital Excellence, Haider Alleg, and José Maria Guido Avila, Global Brand Lead HCP Marketing at Sanofi, to discuss what the future of commercial pharma will look like when the field force can […]
For emerging and mid-sized biopharma, this webinar offers the ultimate guide for how any size company can deliver a personalized omnichannel experience for HCP outreach using AI-driven insights. Hear Sal Paolozza, Senior Director of Sales Operation at Antares Pharma, Doug Caldwell, VP, Commercial Strategy at Veeva and Matthew Van Wingerden, VP of Product Management at […]
EMD Serono & Aktana: Bringing Intelligent Engagement to Every Channel EMD Serono社は、パンデミック前に、より良い医療従事者との関係性構築を推進するべく全米のRep向けにAI搭載推奨システムを装備しました。COVID-19の感染が始まった際、迅速に市場変化の不確実性を予期し、リモート対応に移行し、困っている医療従事者向けの顧客対応をパーソナル化しました ここ数カ月、ライフサイエンス・コマーシャル・プロセス自体が試されてきました。今後に向け不確実なことは多々ありますが、一つだけ確実なことは、新しいオムニチャネル・エンゲージメントがこれまでで最も重要になるということです EMD Serono社N&I Commercial Strategy and Operations部門のSenior DirectorであるJoel VanderMeulen氏とAktana社共同創業者兼PresidentであるDerek Choyのお話をこのWebinarでご覧ください ポストCOVID世界での新興市場トレンド どうコマーシャルチームは「ニューノーマル」に適応できるのか オムニチャネルを成功に導く3つの主要構成要素
The novel coronavirus has threatened public health across the globe, with mandatory quarantines and restricted travel creating complicated business environments. The Aktana team in China has been on the front lines since January helping our impacted clients quickly adapt to maintain go-to-market strategies and relationships with healthcare providers (HCPs). As many cities in China rolled […]
Eli Lilly and Company and Aktana discuss the end of the POA cycle as we know it as the life sciences industry begins to shift towards agile HCP engagement. Learn about: Modern pre-call planning: same data, new opportunities to engage Personalization in pieces: thinking differently about the assets you create A roadmap for coordinated execution: […]